News adivo

adivo signs first major collaboration agreement with Bayer Animal Health to jointly develop species-specific therapeutic monoclonal antibodies to address the demand for innovative pet therapies. We congratulate adivo on this major step and look forward to further successful collaborations.

More

News Implandata

Congratulations to our portfolio company Implandata Ophthalmic Products on the CE certification of the EYEMATE-IO 1.1 microsensor implant for continuous monitoring of intraocular pressure in glaucoma patients! Market entry can thus take place in April 2019.

More

New Investment Analyst

Occident welcomes Dr. Kathrin Chojnowska to the team. Following her PhD in neurobiology, Kathrin joins the life sciences team as an Investment Analyst and supports Cédric Barra with her extensive expertise.

Be part of tomorrow

We’re shaping the future, not just watching it happen. We invest in ground-breaking innovations before they change our lives forever. Are you intrigued by the opportunity to really have an impact in your job and accomplish something meaningful? Join us as a Junior Investment Manager and help shape the future!

More about Junior Investment Manager High-tech

More about Junior Investment Manager Digital

Tomorrow happens in Germany

In recent years, Occident has intensified its investment activities in Germany and we are now ready to take the next step by establishing our own branch office in Munich. We believe that Munich is a great location for our business, thanks to its top international universities and global technology leaders, along with a solid network of renowned investors.

Our goal is clear: we will press on and deepen our existing investment strategy in Germany, by reinforcing and expanding our investment team there as well.

Investment in iThera Medical

Occident invests in the Munich-based diagnostics company iThera Medical together with existing investors Fluxunit – Osram Ventures, Bayern Kapital, BayBG Bayrische Beteiligungsgesellschaft and Extorel in its extended Series C financing round of 9 million euros. The company develops imaging methods for medical diagnostics based on multispectral optoacoustic tomography (MSOT). This laser-enabled technology allows for the evaluation of optical tissue properties and thus enables a more accurate and non-invasive diagnosis in a variety of indications such as cancer and inflammatory diseases. The additional funding will be used for the further development of the MSOT systems and for entry into the clinical market.

More about iThera Medical

Investment in Resistell

Occident invests in the Basel based diagnostic startup Resistell, which develops a technology for more precise and fast antibiotic susceptibility testing. More information in the press release under the following link.

Happy to support

Technology fascinates us, but in this case the challenge is simplicity and robustness. As part of our philanthropic activities, we are pleased to support the aid organisation Aqua Alimenta and its irrigation technology as the key to food security for smallholder families in Odisha, India.

More about Aqua Alimenta
More about projekt Odisha

Offsite Team Meeting in Montafon

A trip to the Austrian Alps allowed the Occident team to work on further improving cooperation and internal processes. Despite bad weather, there were also plenty of opportunities to get to know each other better off the job.

TOP 100 Swiss Startups 2018

Congratulaitons to Lunaphore and Versantis! We are proud that two of our portfolio companies have been voted amongst the top 10 startups in Switzerland.

More about Lunaphore Technologies SA
More about Versantis AG

News 4tiitoo

Controlling the computer with your eyes – this fascinating technology has also made the Frankfurter Allgemeine curious. The complete article can be found under the following the link. (German language)

Or as aptly drafted by VDI, the engineers’ news portal: “PC reads wishes from the eyes” (article in German language under the following link)

Follow-on investment in Lunaphore

Occident participates in the financing round of the Swiss medtech firm Lunaphore that develops innovative next-generation devices for cancer tissue diagnostics. The funds will enable the product’s CE marking and support product launch. More information in the press release under the following link.

Follow-on investment in iMusician

iMusician has shown in recent years that its business model can also be successful internationally. In order to promote further internationalization, iMusician closes another financing round with Occident as lead investor and other investors.

Investment in adivo

Occident invests in the Munich-based biotech company adivo, which develops therapeutic antibodies for pets. More information in the press release under the following link.

News Numbrs

Due to its huge success, Numbrs has attracted the attention of CNN Money. Watch the interview with the founder Martin Saidler at the following link.

News InSphero

InSphero starts promising collaboration with ALPCO on further development of its product range in the area of diabetes research. More

Team Offsite: Mastering challenges together

At AdventureRooms Zurich, the team worked under pressure to explore all the options for escaping from a locked room. Fantastic cooperation in the team and the different skills of each individual team member made this experience a great success. As a reward, there were culinary delights to enjoy at Food Zurich.

Investment in Implandata Ophthalmic Products

Occident participates in the medical device company Implandata Ophthalmic Products in Hannover. More information in the press release under the following link.

Follow-on investment in InSphero

To support the rapid development of InSphero as the leading supplier of 3D microtissues, Occident joined forces with new and existing investors to provide follow-on financing for this Zurich-based biotech firm. This will allow InSphero to reinforce its outstanding position in this fast-growing future market.

News Lunaphore

Occident’s portfolio company Lunaphore is launching a promising collaboration with Perkin Elmer for the quicker analysis of tumor samples.

More

News 4tiitoo

4tiitoo is rolling out a pilot project with Benteler Automotive, using a NUIA platform for efficient gaze-control of selected applications.

More

Offsite team meeting with Asian culinary delights

After an introduction to traditional sake making and Japanese drinking culture, the Occident team enjoyed a sake tasting. Dinner afterwards was a great occasion to explore and enjoy the diverse cuisine of Indonesia.